Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Guzelant G., Ucar D., Esatoglu S. N., Hatemi G., Ozyazgan Y., Yurdakul S., ...Daha Fazla

Clinical and experimental rheumatology, sa.6, ss.86-89, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: Sayı: 6
  • Basım Tarihi: 2017
  • Dergi Adı: Clinical and experimental rheumatology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.86-89
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective. The prognosis of uveitis in Behcet's syndrome (BS) has improved over decades. Whether this is related to the use of more aggressive management strategies is not known.